Acta Neurologica Scandinavica

Cover image for Acta Neurologica Scandinavica

November 1993

Volume 88, Issue S149

Pages 1–65

  1. Original Article

    1. Top of page
    2. Original Article
    1. Alzheimer's disease in its epidemiological context (pages 1–3)

      A. S. Henderson

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04243.x

    2. Biochemical pathology and treatment strategies in Alzheimer's disease: Emphasis on the cholinergic system (pages 4–6)

      B. Winblad, E. Messamore, C. O'Neill and R. Cowburn

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04244.x

    3. The next generation of cholinesterase inhibitors (pages 10–12)

      A. Adem

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04246.x

    4. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy (pages 16–21)

      K. Alhainen and P. J. Riekkinen Sr.

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04248.x

    5. Pharmacokinetic studies of cholinesterase inhibitors (pages 22–25)

      M. Johansson and A. Nordberg

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04249.x

    6. Pharmacodynamic and early clinical studies with velnacrine (pages 26–28)

      K. R. Siegfried

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04250.x

    7. Clinical experiences and biochemical findings with tacrine (THA) (pages 36–38)

      H Nybäck, M Hassan, T Junthé and A Åhlin

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04252.x

    8. Cholinergic therapy in dementia (pages 42–45)

      P. J. Whitehouse

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04254.x

    9. Side effects of long acting cholinesterase inhibitors (pages 53–54)

      B. Beermann

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04256.x

    10. Long-term treatment with tacrine (THA) in Alzheimer's disease—evaluation of neuropsychological data (pages 55–57)

      K. Amberla, A. Nordberg, M. Viitanen and B. Winblad

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04257.x

    11. EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer's disease (pages 58–61)

      M. Shigeta, A. Persson, M. Viitanen, B. Winblad and A. Nordberg

      Version of Record online: 29 JAN 2009 | DOI: 10.1111/j.1600-0404.1993.tb04258.x

SEARCH

SEARCH BY CITATION